ARID1A and nonpapillary renal cell carcinoma: Although the oncogenic pathways activated by SMARCA4 and SMARCA2 in the absence of PBRM1 or ARID1A are currently unknown, they can and should be identified in ccRCC cells and tumors with PBRM1 or ARID1A deficiency.